Cannabidiol: pharmacology and therapeutic targets

SC Britch, S Babalonis, SL Walsh - Psychopharmacology, 2021 - Springer
Rationale Cannabidiol (CBD) products lacking regulatory approval are being used to self-
treat a myriad of conditions and for their unsubstantiated health benefits. The scientific …

Cannabinoids, the endocannabinoid system, and pain: a review of preclinical studies

DP Finn, S Haroutounian, AG Hohmann, E Krane… - Pain, 2021 - journals.lww.com
This narrative review represents an output from the International Association for the Study of
Pain's global task force on the use of cannabis, cannabinoids, and cannabis-based …

Trends in use, pharmacology, and clinical applications of emerging herbal nutraceuticals

EM Williamson, X Liu, AA Izzo - British Journal of …, 2020 - Wiley Online Library
The nutraceuticals market is vast, encompassing many different products with inconsistent
levels of evidence available to support their use. This overview represents a Western …

A cross-sectional study of cannabidiol users

J Corroon, JA Phillips - Cannabis and cannabinoid research, 2018 - liebertpub.com
Introduction: Preclinical and clinical studies suggest that cannabidiol (CBD) found in
Cannabis spp. has broad therapeutic value. CBD products can currently be purchased …

The polypharmacological effects of cannabidiol

J Castillo-Arellano, A Canseco-Alba, SJ Cutler, F León - Molecules, 2023 - mdpi.com
Cannabidiol (CBD) is a major phytocannabinoid present in Cannabis sativa (Linneo, 1753).
This naturally occurring secondary metabolite does not induce intoxication or exhibit the …

Cannabis, a cause for anxiety? A critical appraisal of the anxiogenic and anxiolytic properties

L Sharpe, J Sinclair, A Kramer, M de Manincor… - Journal of translational …, 2020 - Springer
Background Cannabis has been documented for use in alleviating anxiety. However, certain
research has also shown that it can produce feelings of anxiety, panic, paranoia and …

Cannabidiol (CBD) use in psychiatric disorders: A systematic review

S Bonaccorso, A Ricciardi, C Zangani, S Chiappini… - Neurotoxicology, 2019 - Elsevier
Abstract Cannabidiol (CBD) and Δ9-tetrahydrocannabinol (THC) are the most represented
phytocannabinoids in Cannabis sativa plants. However, CBD may present with a different …

Cannabinoids in the landscape of cancer

N Mangal, S Erridge, N Habib, A Sadanandam… - Journal of cancer …, 2021 - Springer
Introduction Cannabinoids are a group of terpenophenolic compounds derived from the
Cannabis sativa L. plant. There is a growing body of evidence from cell culture and animal …

Cannabidiol as a promising strategy to treat and prevent movement disorders?

FF Peres, AC Lima, JEC Hallak, JA Crippa… - Frontiers in …, 2018 - frontiersin.org
Movement disorders such as Parkinson's disease and dyskinesia are highly debilitating
conditions linked to oxidative stress and neurodegeneration. When available, the …

Use of medicinal cannabis and synthetic cannabinoids in post-traumatic stress disorder (PTSD): a systematic review

L Orsolini, S Chiappini, U Volpe, D De Berardis… - Medicina, 2019 - mdpi.com
Background and Objectives: Post-traumatic stress disorder (PTSD) is a common psychiatric
disorder resulting from a traumatic event, is manifested through hyperarousal, anxiety …